Document is current
Any future updates will be listed below
-
Authors
Chen, Shimin https://orcid.org/0000-0001-5289-1309
Dai, Hongshuang
Hu, Shangying
Gao, Tangjie
Chen, Ming
Zhou, Xinghua
Dai, Lizhong
Zhao, Xuelian
Zhao, Fanghui
-
Funding
Funding for this research was provided by:
CAMS Innovation Fund for Medical Sciences (CIFMS, 2021-I2M-1-004)
Special Research Fund for Central Universities, Peking Union Medical College (3332023141)
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 27 June 2025
First Online: 1 August 2025
Declarations
:
: Participants who provided newly collected samples gave written informed consent. For the use of residual samples from previous studies, ethical committee approval was obtained to waive informed consent. This study was approved by the ethics committees of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (NCC/CHCAMS) (Approval No. 22/364-3566).
: Not applicable.
: H.D., T.G., M.C., X.Z. (Zhou Xinghua), and L.D. are employees of Sansure Biotech Inc. H.D., T.G., and M.C. hold stock in Sansure Biotech Inc., while L.D. serves as the president of the company. The other co-authors declare no competing interests.
